KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Return on Invested Capital (2016 - 2025)

Evolent Health has reported Return on Invested Capital over the past 11 years, most recently at 0.65% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.65% for Q4 2025, down 61.0% from a year ago — trailing twelve months through Dec 2025 was 0.65% (down 61.0% YoY), and the annual figure for FY2025 was 0.52%, down 48.0%.
  • Return on Invested Capital for Q4 2025 was 0.65% at Evolent Health, down from 0.02% in the prior quarter.
  • Over the last five years, Return on Invested Capital for EVH hit a ceiling of 0.0% in Q4 2022 and a floor of 0.65% in Q4 2025.
  • Median Return on Invested Capital over the past 5 years was 0.04% (2024), compared with a mean of 0.07%.
  • Biggest five-year swings in Return on Invested Capital: surged 54bps in 2021 and later tumbled -61bps in 2025.
  • Evolent Health's Return on Invested Capital stood at 0.06% in 2021, then surged by 102bps to 0.0% in 2022, then crashed by -2979bps to 0.04% in 2023, then increased by 2bps to 0.04% in 2024, then plummeted by -1713bps to 0.65% in 2025.
  • The last three reported values for Return on Invested Capital were 0.65% (Q4 2025), 0.02% (Q3 2025), and 0.03% (Q2 2025) per Business Quant data.